All Relations between Hyperprolactinemia and dopamine

Publication Sentence Publish Date Extraction Date Species
M Selmanof. Rapid effects of hyperprolactinemia on basal prolactin secretion and dopamine turnover in the medial and lateral median eminence. Endocrinology. vol 116. issue 5. 1985-05-30. PMID:3921346. rapid effects of hyperprolactinemia on basal prolactin secretion and dopamine turnover in the medial and lateral median eminence. 1985-05-30 2023-08-11 rat
D Becú-Villalobos, I M Lacau de Mengido, C Libertu. p-Tyramine, a natural amine, inhibits prolactin release in vivo. Endocrinology. vol 116. issue 5. 1985-05-30. PMID:3987630. the hyperprolactinemia achieved by this last procedure was inhibited by both tyramine and dopamine; tyramine produced the same effect as dopamine at a dose 5 times greater. 1985-05-30 2023-08-11 rat
D Tallo, W B Malarke. Physiologic concentrations of dopamine fail to suppress prolactin secretion in patients with idiopathic hyperprolactinemia or prolactinomas. American journal of obstetrics and gynecology. vol 151. issue 5. 1985-04-23. PMID:3976764. physiologic concentrations of dopamine fail to suppress prolactin secretion in patients with idiopathic hyperprolactinemia or prolactinomas. 1985-04-23 2023-08-11 human
D Tallo, W B Malarke. Physiologic concentrations of dopamine fail to suppress prolactin secretion in patients with idiopathic hyperprolactinemia or prolactinomas. American journal of obstetrics and gynecology. vol 151. issue 5. 1985-04-23. PMID:3976764. several investigators have suggested that normal responsiveness to dopamine is exhibited by pituitary lactotrophs in patients with idiopathic hyperprolactinemia and prolactinomas. 1985-04-23 2023-08-11 human
D Tallo, W B Malarke. Physiologic concentrations of dopamine fail to suppress prolactin secretion in patients with idiopathic hyperprolactinemia or prolactinomas. American journal of obstetrics and gynecology. vol 151. issue 5. 1985-04-23. PMID:3976764. in order to further examine this issue, we infused graded doses of dopamine to normal men and women as well as to patients with idiopathic hyperprolactinemia and prolactinomas. 1985-04-23 2023-08-11 human
I Nicoletti, P Filipponi, L Fedeli, G Gregorini, F Ambrosi, M Sfrappini, F Santeusanio, P Brunett. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 16. issue 12. 1985-04-15. PMID:6441763. the inhibitory effect of various doses of dopamine on serum prl levels was assessed in both normal cycling women and patients with tumoral hyperprolactinemia before and after endogenous catecholamine synthesis inhibition by alpha-methyl-p-tyrosine, a strong and specific tyrosine-hydroxylase inhibitor. 1985-04-15 2023-08-12 human
I Nicoletti, P Filipponi, L Fedeli, G Gregorini, F Ambrosi, M Sfrappini, F Santeusanio, P Brunett. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 16. issue 12. 1985-04-15. PMID:6441763. the mean percent inhibition of baseline prl induced by the various dopamine infusion rates (0.1, 0.5, 1.0 and 2.0 micrograms/kg/min) was similar in regularly cycling women and in patients with tumoral hyperprolactinemia both before and after endogenous catecholamine synthesis inhibition by alpha-methyl-p-tyrosine. 1985-04-15 2023-08-12 human
D G Morgan, C V Mobbs, C P Anderson, Y N Sinha, C E Finc. Hyperprolactinemia fails to increase striatal dopamine receptors in male and female C57BL/6J mice. European journal of pharmacology. vol 107. issue 1. 1985-04-15. PMID:6526068. hyperprolactinemia fails to increase striatal dopamine receptors in male and female c57bl/6j mice. 1985-04-15 2023-08-12 mouse
R L Barbieri, D S Cooper, G H Daniels, D Nathan, A Klibanski, E C Ridgwa. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease. Fertility and sterility. vol 43. issue 1. 1985-02-20. PMID:3917409. in the majority of patients with hyperprolactinemia due to dopamine antagonist medications, trh stimulation did not produce a normal rise in prl. 1985-02-20 2023-08-11 human
I Nicoletti, P Filipponi, L Fedeli, M Sfrappini, G Gregorini, F Ambrosi, F Santeusani. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia. Hormone research. vol 20. issue 3. 1984-12-05. PMID:6436160. restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia. 1984-12-05 2023-08-12 monkey
D Y Shen, A T Guay, M L Silverman, R L Hybels, S R Freidber. Primary intrasellar germinoma in a woman presenting with secondary amenorrhea and hyperprolactinemia. Neurosurgery. vol 15. issue 3. 1984-11-19. PMID:6483157. had dopamine agonists been used initially, amelioration of the hyperprolactinemia and delay in the proper diagnosis and treatment would have occurred. 1984-11-19 2023-08-12 Not clear
A A Luciano, F K Chapler, B M Sherma. Hyperprolactinemia in polycystic ovary syndrome. Fertility and sterility. vol 41. issue 5. 1984-06-07. PMID:6425087. the hyperprolactinemia observed in a significant number of pco patients may reflect a greater deficiency of hypothalamic dopamine, as manifested by the basal elevations of both prolactin and thyrotropin levels. 1984-06-07 2023-08-12 Not clear
S Z Badawy, A Moses, D Streeten, L Marshall, D Marlin, D Notma. Prolactin and thyroid-stimulating hormone responses to thyrotropin-releasing hormone in cases of hyperprolactinemia with normal and abnormal sella tomograms. International journal of fertility. vol 28. issue 4. 1984-04-04. PMID:6142012. these results suggest an inhibitory action of hypothalamic dopamine on the response of both prolactin and tsh to trh in patients with hyperprolactinemia. 1984-04-04 2023-08-12 Not clear
J P Bercovici, S Khoury, D Tater, G Besson, J Carof. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 37. issue 5. 1984-03-21. PMID:6661508. fifteen normal menstruating women in the early follicular phase of their menstrual cycle, fifteen patients with prolactin secreting adenomas, two patients with a suprahypophysial lesion and an hyperprolactinemia, underwent a dopamine infusion (4 micrograms/kg/mn for four hours and an orally administration of domperidone (40 mg). 1984-03-21 2023-08-12 human
L De Marinis, A Mancini, G Maira, C Anile, E Menini, A Barbarin. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. The Journal of clinical endocrinology and metabolism. vol 58. issue 3. 1984-03-12. PMID:6693543. in 24 patients who had a prl-secreting pituitary adenoma, diagnosed by pituitary dynamic function tests and ct scan, and confirmed at surgery, the tsh response to a dopamine (da)-antagonist drug, metoclopramide (mcp), was studied pre- and postoperatively to elucidate whether altered da tone was present and related to hyperprolactinemia. 1984-03-12 2023-08-12 Not clear
D Berg, H K Rjosk, F Jänicke, K von Werde. [Treatment of hyperprolactinemic amenorrhea by pulsatile administration of gonadotropin-releasing hormone]. Geburtshilfe und Frauenheilkunde. vol 43. issue 11. 1984-02-20. PMID:6360789. the pulsatile intravenous administration of gnrh is apparently a viable alternative plan of management in patients with a moderate hyperprolactinemia and incompatibility to dopamine agonists to the treatment with gonadotropins which was in use up to now. 1984-02-20 2023-08-12 Not clear
T W Wong, T M Jone. Hyperprolactinemia and male infertility. Archives of pathology & laboratory medicine. vol 108. issue 1. 1984-02-14. PMID:6546335. the usual known causes of hyperprolactinemia, such as pituitary or suprasellar tumors, hypothyroidism, intake of certain medications that deplete the dopamine levels of the hypothalamus or block the action of dopamine on the pituitary, were absent. 1984-02-14 2023-08-12 Not clear
K Y Ho, G A Smythe, M Duncan, L Lazaru. Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism. The Journal of clinical endocrinology and metabolism. vol 58. issue 1. 1984-01-26. PMID:6689678. dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism. 1984-01-26 2023-08-12 human
K Y Ho, G A Smythe, M Duncan, L Lazaru. Dopamine infusion studies in patients with pathological hyperprolactinemia: evidence of normal prolactin suppressibility but abnormal dopamine metabolism. The Journal of clinical endocrinology and metabolism. vol 58. issue 1. 1984-01-26. PMID:6689678. the cause of pathological hyperprolactinemia (php) is not known, although it has been postulated that lactotroph refractoriness to dopamine (da) is an important factor. 1984-01-26 2023-08-12 human
P S Kalra, J W Simpkins, W G Luttge, S P Kalr. Effects on male sex behavior and preoptic dopamine neurons of hyperprolactinemia induced by MtTW15 pituitary tumors. Endocrinology. vol 113. issue 6. 1984-01-07. PMID:6641626. effects on male sex behavior and preoptic dopamine neurons of hyperprolactinemia induced by mttw15 pituitary tumors. 1984-01-07 2023-08-12 rat